ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Piroxicam Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-33G5654
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Piroxicam Market Insights and Forecast to 2028
BUY CHAPTERS

Global Piroxicam Market Research Report 2025

Code: QYRE-Auto-33G5654
Report
September 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
TEVA
Mylan NV
Nostrum
DCPC
FANGMING
Jinghua
Jumpcan
Technilab Pharma
Apotex Corporation
Keltman Pharmaceuticals
Genpharm
Bayer
PLX Pharma
Chiesi
SK Chemicals
Bioglan Laboratories
APR
CJ HealthCare
Skyepharma
Changzhou Siyao Pharmaceutical
Shanxi Yunpeng Pharmaceutical

Piroxicam Market

The global market for Piroxicam was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.
North American market for Piroxicam is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Piroxicam is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Piroxicam in Tendonitis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Piroxicam include Pfizer, Teva, Mylan, Nostrum, DCPC, FANGMING, JINGHUA, JUMPCAN, Technilab Pharma, Apotex Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Piroxicam, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Piroxicam.
The Piroxicam market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Piroxicam market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Piroxicam companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Piroxicam Market Report

Report Metric Details
Report Name Piroxicam Market
Segment by Type
  • by Dosage Form
  • by Route
Segment by Application
  • Tendonitis
  • Systemic Traumatic Pain
  • Musculoskeletal Pain
  • Contraception
  • Rheumatoid Arthritis
  • Chronic Infectious Arthritis
  • Osteoarthritis
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Teva, Mylan, Nostrum, DCPC, FANGMING, JINGHUA, JUMPCAN, Technilab Pharma, Apotex Corporation, Keltman Pharmaceuticals, Genpharm, Bayer, PLX Pharma, Chiesi, SK Chemicals, Bioglan Laboratories, APR, CJ HealthCare, SkyePharma, Changzhou Siyao Pharmaceutical, Shanxi Yunpeng Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Piroxicam company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Piroxicam Market report?

Ans: The main players in the Piroxicam Market are Pfizer, Teva, Mylan, Nostrum, DCPC, FANGMING, JINGHUA, JUMPCAN, Technilab Pharma, Apotex Corporation, Keltman Pharmaceuticals, Genpharm, Bayer, PLX Pharma, Chiesi, SK Chemicals, Bioglan Laboratories, APR, CJ HealthCare, SkyePharma, Changzhou Siyao Pharmaceutical, Shanxi Yunpeng Pharmaceutical

What are the Application segmentation covered in the Piroxicam Market report?

Ans: The Applications covered in the Piroxicam Market report are Tendonitis, Systemic Traumatic Pain, Musculoskeletal Pain, Contraception, Rheumatoid Arthritis, Chronic Infectious Arthritis, Osteoarthritis, Other

What are the Type segmentation covered in the Piroxicam Market report?

Ans: The Types covered in the Piroxicam Market report are by Dosage Form, by Route

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Piroxicam Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 by Dosage Form
1.2.3 by Route
1.3 Market by Application
1.3.1 Global Piroxicam Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tendonitis
1.3.3 Systemic Traumatic Pain
1.3.4 Musculoskeletal Pain
1.3.5 Contraception
1.3.6 Rheumatoid Arthritis
1.3.7 Chronic Infectious Arthritis
1.3.8 Osteoarthritis
1.3.9 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Piroxicam Market Perspective (2020-2031)
2.2 Global Piroxicam Growth Trends by Region
2.2.1 Global Piroxicam Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Piroxicam Historic Market Size by Region (2020-2025)
2.2.3 Piroxicam Forecasted Market Size by Region (2026-2031)
2.3 Piroxicam Market Dynamics
2.3.1 Piroxicam Industry Trends
2.3.2 Piroxicam Market Drivers
2.3.3 Piroxicam Market Challenges
2.3.4 Piroxicam Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Piroxicam Players by Revenue
3.1.1 Global Top Piroxicam Players by Revenue (2020-2025)
3.1.2 Global Piroxicam Revenue Market Share by Players (2020-2025)
3.2 Global Piroxicam Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Piroxicam Revenue
3.4 Global Piroxicam Market Concentration Ratio
3.4.1 Global Piroxicam Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Piroxicam Revenue in 2024
3.5 Global Key Players of Piroxicam Head office and Area Served
3.6 Global Key Players of Piroxicam, Product and Application
3.7 Global Key Players of Piroxicam, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Piroxicam Breakdown Data by Type
4.1 Global Piroxicam Historic Market Size by Type (2020-2025)
4.2 Global Piroxicam Forecasted Market Size by Type (2026-2031)
5 Piroxicam Breakdown Data by Application
5.1 Global Piroxicam Historic Market Size by Application (2020-2025)
5.2 Global Piroxicam Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Piroxicam Market Size (2020-2031)
6.2 North America Piroxicam Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Piroxicam Market Size by Country (2020-2025)
6.4 North America Piroxicam Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Piroxicam Market Size (2020-2031)
7.2 Europe Piroxicam Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Piroxicam Market Size by Country (2020-2025)
7.4 Europe Piroxicam Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Piroxicam Market Size (2020-2031)
8.2 Asia-Pacific Piroxicam Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Piroxicam Market Size by Region (2020-2025)
8.4 Asia-Pacific Piroxicam Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Piroxicam Market Size (2020-2031)
9.2 Latin America Piroxicam Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Piroxicam Market Size by Country (2020-2025)
9.4 Latin America Piroxicam Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Piroxicam Market Size (2020-2031)
10.2 Middle East & Africa Piroxicam Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Piroxicam Market Size by Country (2020-2025)
10.4 Middle East & Africa Piroxicam Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Piroxicam Introduction
11.1.4 Pfizer Revenue in Piroxicam Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Piroxicam Introduction
11.2.4 Teva Revenue in Piroxicam Business (2020-2025)
11.2.5 Teva Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Piroxicam Introduction
11.3.4 Mylan Revenue in Piroxicam Business (2020-2025)
11.3.5 Mylan Recent Development
11.4 Nostrum
11.4.1 Nostrum Company Details
11.4.2 Nostrum Business Overview
11.4.3 Nostrum Piroxicam Introduction
11.4.4 Nostrum Revenue in Piroxicam Business (2020-2025)
11.4.5 Nostrum Recent Development
11.5 DCPC
11.5.1 DCPC Company Details
11.5.2 DCPC Business Overview
11.5.3 DCPC Piroxicam Introduction
11.5.4 DCPC Revenue in Piroxicam Business (2020-2025)
11.5.5 DCPC Recent Development
11.6 FANGMING
11.6.1 FANGMING Company Details
11.6.2 FANGMING Business Overview
11.6.3 FANGMING Piroxicam Introduction
11.6.4 FANGMING Revenue in Piroxicam Business (2020-2025)
11.6.5 FANGMING Recent Development
11.7 JINGHUA
11.7.1 JINGHUA Company Details
11.7.2 JINGHUA Business Overview
11.7.3 JINGHUA Piroxicam Introduction
11.7.4 JINGHUA Revenue in Piroxicam Business (2020-2025)
11.7.5 JINGHUA Recent Development
11.8 JUMPCAN
11.8.1 JUMPCAN Company Details
11.8.2 JUMPCAN Business Overview
11.8.3 JUMPCAN Piroxicam Introduction
11.8.4 JUMPCAN Revenue in Piroxicam Business (2020-2025)
11.8.5 JUMPCAN Recent Development
11.9 Technilab Pharma
11.9.1 Technilab Pharma Company Details
11.9.2 Technilab Pharma Business Overview
11.9.3 Technilab Pharma Piroxicam Introduction
11.9.4 Technilab Pharma Revenue in Piroxicam Business (2020-2025)
11.9.5 Technilab Pharma Recent Development
11.10 Apotex Corporation
11.10.1 Apotex Corporation Company Details
11.10.2 Apotex Corporation Business Overview
11.10.3 Apotex Corporation Piroxicam Introduction
11.10.4 Apotex Corporation Revenue in Piroxicam Business (2020-2025)
11.10.5 Apotex Corporation Recent Development
11.11 Keltman Pharmaceuticals
11.11.1 Keltman Pharmaceuticals Company Details
11.11.2 Keltman Pharmaceuticals Business Overview
11.11.3 Keltman Pharmaceuticals Piroxicam Introduction
11.11.4 Keltman Pharmaceuticals Revenue in Piroxicam Business (2020-2025)
11.11.5 Keltman Pharmaceuticals Recent Development
11.12 Genpharm
11.12.1 Genpharm Company Details
11.12.2 Genpharm Business Overview
11.12.3 Genpharm Piroxicam Introduction
11.12.4 Genpharm Revenue in Piroxicam Business (2020-2025)
11.12.5 Genpharm Recent Development
11.13 Bayer
11.13.1 Bayer Company Details
11.13.2 Bayer Business Overview
11.13.3 Bayer Piroxicam Introduction
11.13.4 Bayer Revenue in Piroxicam Business (2020-2025)
11.13.5 Bayer Recent Development
11.14 PLX Pharma
11.14.1 PLX Pharma Company Details
11.14.2 PLX Pharma Business Overview
11.14.3 PLX Pharma Piroxicam Introduction
11.14.4 PLX Pharma Revenue in Piroxicam Business (2020-2025)
11.14.5 PLX Pharma Recent Development
11.15 Chiesi
11.15.1 Chiesi Company Details
11.15.2 Chiesi Business Overview
11.15.3 Chiesi Piroxicam Introduction
11.15.4 Chiesi Revenue in Piroxicam Business (2020-2025)
11.15.5 Chiesi Recent Development
11.16 SK Chemicals
11.16.1 SK Chemicals Company Details
11.16.2 SK Chemicals Business Overview
11.16.3 SK Chemicals Piroxicam Introduction
11.16.4 SK Chemicals Revenue in Piroxicam Business (2020-2025)
11.16.5 SK Chemicals Recent Development
11.17 Bioglan Laboratories
11.17.1 Bioglan Laboratories Company Details
11.17.2 Bioglan Laboratories Business Overview
11.17.3 Bioglan Laboratories Piroxicam Introduction
11.17.4 Bioglan Laboratories Revenue in Piroxicam Business (2020-2025)
11.17.5 Bioglan Laboratories Recent Development
11.18 APR
11.18.1 APR Company Details
11.18.2 APR Business Overview
11.18.3 APR Piroxicam Introduction
11.18.4 APR Revenue in Piroxicam Business (2020-2025)
11.18.5 APR Recent Development
11.19 CJ HealthCare
11.19.1 CJ HealthCare Company Details
11.19.2 CJ HealthCare Business Overview
11.19.3 CJ HealthCare Piroxicam Introduction
11.19.4 CJ HealthCare Revenue in Piroxicam Business (2020-2025)
11.19.5 CJ HealthCare Recent Development
11.20 SkyePharma
11.20.1 SkyePharma Company Details
11.20.2 SkyePharma Business Overview
11.20.3 SkyePharma Piroxicam Introduction
11.20.4 SkyePharma Revenue in Piroxicam Business (2020-2025)
11.20.5 SkyePharma Recent Development
11.21 Changzhou Siyao Pharmaceutical
11.21.1 Changzhou Siyao Pharmaceutical Company Details
11.21.2 Changzhou Siyao Pharmaceutical Business Overview
11.21.3 Changzhou Siyao Pharmaceutical Piroxicam Introduction
11.21.4 Changzhou Siyao Pharmaceutical Revenue in Piroxicam Business (2020-2025)
11.21.5 Changzhou Siyao Pharmaceutical Recent Development
11.22 Shanxi Yunpeng Pharmaceutical
11.22.1 Shanxi Yunpeng Pharmaceutical Company Details
11.22.2 Shanxi Yunpeng Pharmaceutical Business Overview
11.22.3 Shanxi Yunpeng Pharmaceutical Piroxicam Introduction
11.22.4 Shanxi Yunpeng Pharmaceutical Revenue in Piroxicam Business (2020-2025)
11.22.5 Shanxi Yunpeng Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
TEVA
Mylan NV
Nostrum
DCPC
FANGMING
Jinghua
Jumpcan
Technilab Pharma
Apotex Corporation
Keltman Pharmaceuticals
Genpharm
Bayer
PLX Pharma
Chiesi
SK Chemicals
Bioglan Laboratories
APR
CJ HealthCare
Skyepharma
Changzhou Siyao Pharmaceutical
Shanxi Yunpeng Pharmaceutical
List of Tables
 Table 1. Global Piroxicam Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of by Dosage Form
 Table 3. Key Players of by Route
 Table 4. Global Piroxicam Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Piroxicam Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Piroxicam Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Piroxicam Market Share by Region (2020-2025)
 Table 8. Global Piroxicam Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Piroxicam Market Share by Region (2026-2031)
 Table 10. Piroxicam Market Trends
 Table 11. Piroxicam Market Drivers
 Table 12. Piroxicam Market Challenges
 Table 13. Piroxicam Market Restraints
 Table 14. Global Piroxicam Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Piroxicam Market Share by Players (2020-2025)
 Table 16. Global Top Piroxicam Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piroxicam as of 2024)
 Table 17. Ranking of Global Top Piroxicam Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Piroxicam Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Piroxicam, Headquarters and Area Served
 Table 20. Global Key Players of Piroxicam, Product and Application
 Table 21. Global Key Players of Piroxicam, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Piroxicam Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Piroxicam Revenue Market Share by Type (2020-2025)
 Table 25. Global Piroxicam Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Piroxicam Revenue Market Share by Type (2026-2031)
 Table 27. Global Piroxicam Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Piroxicam Revenue Market Share by Application (2020-2025)
 Table 29. Global Piroxicam Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Piroxicam Revenue Market Share by Application (2026-2031)
 Table 31. North America Piroxicam Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Piroxicam Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Piroxicam Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Piroxicam Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Piroxicam Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Piroxicam Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Piroxicam Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Piroxicam Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Piroxicam Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Piroxicam Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Piroxicam Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Piroxicam Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Piroxicam Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Piroxicam Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Piroxicam Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Pfizer Company Details
 Table 47. Pfizer Business Overview
 Table 48. Pfizer Piroxicam Product
 Table 49. Pfizer Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 50. Pfizer Recent Development
 Table 51. Teva Company Details
 Table 52. Teva Business Overview
 Table 53. Teva Piroxicam Product
 Table 54. Teva Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 55. Teva Recent Development
 Table 56. Mylan Company Details
 Table 57. Mylan Business Overview
 Table 58. Mylan Piroxicam Product
 Table 59. Mylan Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 60. Mylan Recent Development
 Table 61. Nostrum Company Details
 Table 62. Nostrum Business Overview
 Table 63. Nostrum Piroxicam Product
 Table 64. Nostrum Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 65. Nostrum Recent Development
 Table 66. DCPC Company Details
 Table 67. DCPC Business Overview
 Table 68. DCPC Piroxicam Product
 Table 69. DCPC Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 70. DCPC Recent Development
 Table 71. FANGMING Company Details
 Table 72. FANGMING Business Overview
 Table 73. FANGMING Piroxicam Product
 Table 74. FANGMING Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 75. FANGMING Recent Development
 Table 76. JINGHUA Company Details
 Table 77. JINGHUA Business Overview
 Table 78. JINGHUA Piroxicam Product
 Table 79. JINGHUA Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 80. JINGHUA Recent Development
 Table 81. JUMPCAN Company Details
 Table 82. JUMPCAN Business Overview
 Table 83. JUMPCAN Piroxicam Product
 Table 84. JUMPCAN Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 85. JUMPCAN Recent Development
 Table 86. Technilab Pharma Company Details
 Table 87. Technilab Pharma Business Overview
 Table 88. Technilab Pharma Piroxicam Product
 Table 89. Technilab Pharma Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 90. Technilab Pharma Recent Development
 Table 91. Apotex Corporation Company Details
 Table 92. Apotex Corporation Business Overview
 Table 93. Apotex Corporation Piroxicam Product
 Table 94. Apotex Corporation Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 95. Apotex Corporation Recent Development
 Table 96. Keltman Pharmaceuticals Company Details
 Table 97. Keltman Pharmaceuticals Business Overview
 Table 98. Keltman Pharmaceuticals Piroxicam Product
 Table 99. Keltman Pharmaceuticals Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 100. Keltman Pharmaceuticals Recent Development
 Table 101. Genpharm Company Details
 Table 102. Genpharm Business Overview
 Table 103. Genpharm Piroxicam Product
 Table 104. Genpharm Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 105. Genpharm Recent Development
 Table 106. Bayer Company Details
 Table 107. Bayer Business Overview
 Table 108. Bayer Piroxicam Product
 Table 109. Bayer Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 110. Bayer Recent Development
 Table 111. PLX Pharma Company Details
 Table 112. PLX Pharma Business Overview
 Table 113. PLX Pharma Piroxicam Product
 Table 114. PLX Pharma Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 115. PLX Pharma Recent Development
 Table 116. Chiesi Company Details
 Table 117. Chiesi Business Overview
 Table 118. Chiesi Piroxicam Product
 Table 119. Chiesi Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 120. Chiesi Recent Development
 Table 121. SK Chemicals Company Details
 Table 122. SK Chemicals Business Overview
 Table 123. SK Chemicals Piroxicam Product
 Table 124. SK Chemicals Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 125. SK Chemicals Recent Development
 Table 126. Bioglan Laboratories Company Details
 Table 127. Bioglan Laboratories Business Overview
 Table 128. Bioglan Laboratories Piroxicam Product
 Table 129. Bioglan Laboratories Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 130. Bioglan Laboratories Recent Development
 Table 131. APR Company Details
 Table 132. APR Business Overview
 Table 133. APR Piroxicam Product
 Table 134. APR Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 135. APR Recent Development
 Table 136. CJ HealthCare Company Details
 Table 137. CJ HealthCare Business Overview
 Table 138. CJ HealthCare Piroxicam Product
 Table 139. CJ HealthCare Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 140. CJ HealthCare Recent Development
 Table 141. SkyePharma Company Details
 Table 142. SkyePharma Business Overview
 Table 143. SkyePharma Piroxicam Product
 Table 144. SkyePharma Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 145. SkyePharma Recent Development
 Table 146. Changzhou Siyao Pharmaceutical Company Details
 Table 147. Changzhou Siyao Pharmaceutical Business Overview
 Table 148. Changzhou Siyao Pharmaceutical Piroxicam Product
 Table 149. Changzhou Siyao Pharmaceutical Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 150. Changzhou Siyao Pharmaceutical Recent Development
 Table 151. Shanxi Yunpeng Pharmaceutical Company Details
 Table 152. Shanxi Yunpeng Pharmaceutical Business Overview
 Table 153. Shanxi Yunpeng Pharmaceutical Piroxicam Product
 Table 154. Shanxi Yunpeng Pharmaceutical Revenue in Piroxicam Business (2020-2025) & (US$ Million)
 Table 155. Shanxi Yunpeng Pharmaceutical Recent Development
 Table 156. Research Programs/Design for This Report
 Table 157. Key Data Information from Secondary Sources
 Table 158. Key Data Information from Primary Sources
 Table 159. Authors List of This Report


List of Figures
 Figure 1. Piroxicam Picture
 Figure 2. Global Piroxicam Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Piroxicam Market Share by Type: 2024 VS 2031
 Figure 4. by Dosage Form Features
 Figure 5. by Route Features
 Figure 6. Global Piroxicam Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Piroxicam Market Share by Application: 2024 VS 2031
 Figure 8. Tendonitis Case Studies
 Figure 9. Systemic Traumatic Pain Case Studies
 Figure 10. Musculoskeletal Pain Case Studies
 Figure 11. Contraception Case Studies
 Figure 12. Rheumatoid Arthritis Case Studies
 Figure 13. Chronic Infectious Arthritis Case Studies
 Figure 14. Osteoarthritis Case Studies
 Figure 15. Other Case Studies
 Figure 16. Piroxicam Report Years Considered
 Figure 17. Global Piroxicam Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Piroxicam Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Piroxicam Market Share by Region: 2024 VS 2031
 Figure 20. Global Piroxicam Market Share by Players in 2024
 Figure 21. Global Top Piroxicam Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piroxicam as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Piroxicam Revenue in 2024
 Figure 23. North America Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Piroxicam Market Share by Country (2020-2031)
 Figure 25. United States Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Piroxicam Market Share by Country (2020-2031)
 Figure 29. Germany Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Piroxicam Market Share by Region (2020-2031)
 Figure 37. China Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Piroxicam Market Share by Country (2020-2031)
 Figure 45. Mexico Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Piroxicam Market Share by Country (2020-2031)
 Figure 49. Turkey Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Piroxicam Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Pfizer Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 53. Teva Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 54. Mylan Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 55. Nostrum Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 56. DCPC Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 57. FANGMING Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 58. JINGHUA Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 59. JUMPCAN Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 60. Technilab Pharma Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 61. Apotex Corporation Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 62. Keltman Pharmaceuticals Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 63. Genpharm Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 64. Bayer Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 65. PLX Pharma Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 66. Chiesi Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 67. SK Chemicals Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 68. Bioglan Laboratories Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 69. APR Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 70. CJ HealthCare Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 71. SkyePharma Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 72. Changzhou Siyao Pharmaceutical Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 73. Shanxi Yunpeng Pharmaceutical Revenue Growth Rate in Piroxicam Business (2020-2025)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Piroxicam Patch Market Research Report 2024
Global Lornoxicam Tablets Market Research Report 2024
Global Meloxicam Drugs Market Research Report 2024
Global Rofecoxib Market Insights Forecast to 2030
Cox 2 Inhibitors Market
Global Celecoxib Market Insights Forecast to 2030
Global Cyclooxygenase 2 Inhibitor Market Research Report 2024
Global Tenoxicam Market Research Report 2024
Global Celecoxib Capsule Market Insights Forecast to 2030
Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025
Global Nonsteroidal Anti Inflammatory Drugs NSAIDs Market Research Report 2024
Piroxicam API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lornoxicam Market Research Report 2024
Global Aceclofenac Market Research Report 2024
Global Meloxicam Market Research Report 2024
Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030
Global Cyclooxygenase 2 Inhibitor COVID 19 Market Research Report 2024
Global Loxoprofen Market Research Report 2024
Global Carprofen Market Research Report 2025
Global Tiaprofenic Acid Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions